Back to Search
COREY SPEERS, M.D., PH.D.
M.D., PH.D.
Radiation Oncology Physician
NPI: 1932429172IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
51413(AL)4301097991(MI)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
BAYLOR COLLEGE OF MEDICINE
Class of 2010
Research & Publications (20)
A phase II trial of a neoadjuvant platinum regimen for locally advanced breast cancer: pathologic response, long-term follow-up, and correlation with biomarkers.
PMID 19661040·Clin Breast Cancer·2009
3-trial
Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy.
PMID 19018080·J Clin Oncol·2009
8-other
Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
PMID 18676091·Int J Radiat Oncol Biol Phys·2009
8-other
Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence.
PMID 19082705·Breast Cancer Res Treat·2009
8-other
Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.
PMID 19237634·J Clin Oncol·2009
8-other
Breast cancer prevention using calcium and vitamin D: a bright future?
PMID 19001596·J Natl Cancer Inst·2008
8-other
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
PMID 19001334·J Clin Oncol·2008
8-other
Identification of cancer care and protocol characteristics associated with recruitment in breast cancer clinical trials.
PMID 18802158·J Clin Oncol·2008
8-other
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
PMID 18194560·Breast Cancer Res·2008
2-rct
Optimizing the use of 17P in pregnant managed Medicaid members.
PMID 18274315·Manag Care·2008
4-observational
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
PMID 18286526·Cancer·2008
8-other
Survival outcome and cost-effectiveness with docetaxel and paclitaxel in patients with metastatic breast cancer: a population-based evaluation.
PMID 18006892·Ann Oncol·2008
4-observational
The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer.
PMID 17647245·Cancer·2007
8-other
Method of detection of new contralateral primary breast cancer in younger versus older women.
PMID 17919351·Clin Breast Cancer·2007
4-observational
Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.
PMID 17030545·Ann Oncol·2007
8-other
Is mastectomy superior to breast-conserving treatment for young women?
PMID 17275207·Int J Radiat Oncol Biol Phys·2007
4-observational
A retrospective study of the effect of participation in screening mammography on the use of chemotherapy and breast conserving surgery.
PMID 17290404·Int J Cancer·2007
8-other
Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer : comparison of cohorts treated with and without tamoxifen.
PMID 17510927·Cancer·2007
4-observational
Anemia is a common but neglected complication of adjuvant chemotherapy for early breast cancer.
PMID 18080014·Curr Oncol·2007
8-other
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival.
PMID 17116944·J Clin Oncol·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1500 E MEDICAL CENTER DR
ANN ARBOR, MI 48109 - Phone
- (734) 936-4300
Quick Facts
- NPI
- 1932429172
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile